Patented Products 
 Oncology Formulations
  Therapeutic
    
Segments
 Oncology API
 Specialty APIs

 Glycopyrrolate

 Methocarbamol

 Chiral intermediates
Methocarbamol
Robinaxol Methocarbamol 350mg + Paracetamol 250mg
Robinaxol d Methocarbamol 500mg + Diclofenac Potassium 50mg + Paracetamol 325mg
 

Present

Introduced Patented Products based on NDDS
(Marketed in India and out-Licensed for the Developing Countries)

  

Future

Patents driven by NDDS, Nano and Dendrimers
(To be marketed in India and to be out Licensed to the developed countries)

 
   
© 2001 - 2007 Khandelwal Laboratories Pvt. Ltd. All rights reserved.